These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10345434)

  • 21. Cost-effective compliance for the small provider.
    Fedor FP
    Healthc Financ Manage; 2000 Jul; 54(7):56-60. PubMed ID: 11009826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis and recommendations on the draft OIG compliance program for individual and small group physician practices.
    Norris S
    Health Care Law Mon; 2000 Jul; ():3-15. PubMed ID: 11066642
    [No Abstract]   [Full Text] [Related]  

  • 23. Designing compliance programs that foster ethical behavior.
    Lovitky JA; Ahern J
    Healthc Financ Manage; 1999 Mar; 53(3):38, 40-2. PubMed ID: 10351054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why should your practice perform compliance audits based on the latest OIG Work Plan?
    Hammon M
    J Okla State Med Assoc; 2005 Mar; 98(3):95-7. PubMed ID: 15822723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the OIG model compliance programs to fight fraud.
    Lovitky JA; Ahern J
    Healthc Financ Manage; 2002 Mar; 56(3):64-8. PubMed ID: 11899726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Billing company compliance program guidelines published by OIG.
    Wachler AB; Avery PA
    Health Care Law Mon; 1999 Apr; ():3-7. PubMed ID: 10351770
    [No Abstract]   [Full Text] [Related]  

  • 27. When you hear that whistle blowing. How trustees can reduce the threat of "qui tam" lawsuits.
    Stern AL
    Trustee; 1999 Jun; 52(6):6-9. PubMed ID: 10539692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plan for 2009: learn from 2008 the "big 3" violations.
    Dumas T
    MLO Med Lab Obs; 2009 Jan; 41(1):35. PubMed ID: 19244927
    [No Abstract]   [Full Text] [Related]  

  • 29. Voluntary disclosure by health care providers: should you do it?
    Caccia RJ; Falk RN
    J Med Pract Manage; 2001; 16(4):211-2. PubMed ID: 11317582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "It's a physician's duty to expose fraud if he suspects it".
    Rice B
    Med Econ; 1999 Sep; 76(18):154-6, 161-2, 165-6. PubMed ID: 10621375
    [No Abstract]   [Full Text] [Related]  

  • 31. White coat warriors: capitation and compliance send labs into a battle for survival.
    Marietti C
    Healthc Inform; 1999 Jun; 16(6):43-4, 46-9. PubMed ID: 10557641
    [No Abstract]   [Full Text] [Related]  

  • 32. OIG compliance guidance for third-party billing companies released.
    Patient Acc; 1999 Jan; 22(1):4. PubMed ID: 10345763
    [No Abstract]   [Full Text] [Related]  

  • 33. Revised disclosure standard presents new compliance challenges.
    Hosp Peer Rev; 2002 Jul; 27(7):89-91. PubMed ID: 12120020
    [No Abstract]   [Full Text] [Related]  

  • 34. What you need to know about the 2004 OIG work plan.
    Siegel S
    Health Care Law Mon; 2003 Dec; ():3-12. PubMed ID: 14712524
    [No Abstract]   [Full Text] [Related]  

  • 35. The new hospice compliance plan: defining and addressing risk areas. Part 2.
    Jones DH; Woods K
    Caring; 2000 Jun; 19(6):34-7. PubMed ID: 11010140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-disclosure disincentives. Feds must offer stronger protections to encourage providers to voluntarily report misconduct.
    Burke S
    Mod Healthc; 2000 Sep; 30(40):42. PubMed ID: 11186648
    [No Abstract]   [Full Text] [Related]  

  • 37. Implications of the Illinois Blue Cross Medicare settlement.
    Humphrey CJ
    Home Healthc Nurse Manag; 1999; 3(1):2-3. PubMed ID: 10544346
    [No Abstract]   [Full Text] [Related]  

  • 38. Bondholder disclosure and Sarbanes-Oxley: how one medical center aligned best practices.
    O'Neil PS; Cutting TC
    Healthc Financ Manage; 2005 Aug; 59(8):68-70, 72-3. PubMed ID: 16119126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OIG proposes draft compliance program guidance for nursing facilities.
    Natl Rep Subacute Care; 1999 Nov; 7(23):1-4. PubMed ID: 10724560
    [No Abstract]   [Full Text] [Related]  

  • 40. Designing around patents: a guideline.
    Wang SJ
    Nat Biotechnol; 2008 May; 26(5):519-22. PubMed ID: 18464780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.